The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

TWO FREEDOM SQUARE, 11955 FREEDOM DRIVE, RESTON, VA 20190-5675, USA
Tel:
Work +1 571 203 2700
Fax:
Fax +1 202 408 4400
Web:
www.finnegan.com

Charles E. Lipsey

Tel:
Work +1 571 203 2755
Email:
Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Work Department

Intellectual Property

Career

Charles Lipsey focuses his practice on intellectual property litigation, particularly patent infringement litigation. He has handled cases covering a diverse spectrum of mechanical, chemical, and electrical technologies, with an emphasis on cases involving biotechnology and pharmaceutical chemistry. Since joining Finnegan in 1978, Mr. Lipsey has amassed a wealth of experience in patent infringement litigation, patent arbitration proceedings, and patent interferences.

Member

• The District of Columbia Bar • Virginia State Bar • American Bar Association • American Intellectual Property Law Association

Education

George Washington University, National Law Center, LL.M., Patent and Trademark Regulation Law, with highest honors, 1981; George Washington University Law School, J.D., high honors, 1977; Georgia Institute of Technology, B.S., Chemical Engineering, 1972


United States: Intellectual property

Patent litigation: full coverage

Within: Leading lawyers

Charles Lipsey - Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Within: Patent litigation: full coverage

Finnegan, Henderson, Farabow, Garrett & Dunner LLP’s ‘top-tier’ group provides ‘an excellent level of service and business-oriented advice, and has strong knowledge of IP topics’. Reston-based Charles Lipsey successfully represented Forest Laboratories in Hatch-Waxman litigation against generics manufacturer Mylan concerning the Savella fibromyalgia treatment; all asserted patents were found to be valid and infringed. In Palo Alto, Erik Puknys and Lily Lim represented ABBYY and Lexmark International in a case brought by Nuance Communications, obtaining a unanimous defense verdict in US district court and a successful affirmation at the Federal Circuit. Washington DC's Michael Jakes handles technology and medical devices-related cases; he recently acted for PPC Broadband in two related appeals to a Patent Trial and Appeal Board (PTAB) decision which adversely affected the client’s coaxial cable connector patents, and represented Philips Electronics in three cases against ZOLL Medical concerning various medical device technologies. Also in Washington DC are firm chair James Monroe, managing partner Mark Sweet and litigation head Gerald Ivey.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • New requirement for all issuers operating on the Luxembourg Stock Exchange

    On 10 August 2017 the Luxembourg Stock Exchange announced that all domestic and foreign issuers operating on the regulated market (Bourse de Luxembourg) or on the multilateral trading facility (Euro MTF) of the Luxembourg Stock Exchange must provide their legal entity identifier (“LEI ”) codes to the Luxembourg Stock Exchange before 15 September 2017.
  • Luxembourg law on the exploration and use of space resources entered into force

    The Luxembourg law on the exploration and use of space resources of 20 July 2017 entered into force on 2 August 2017 and placed Luxembourg among the most innovative space-oriented nations in the world.
  • VAT in the GCC – Q&A updates from the UAE Ministry of Finance

    On 9 July the United Arab Emirates (UAE) Ministry of Finance (MOF) published an update of the Value Added Tax (VAT) FAQ section of its website.
  • PRIIPs KID: The final pieces of the puzzle

    The pieces of the puzzle are finally falling into place. The long-awaited level 3 and 4 measures have been published earlier this week, half a year before the PRIIPs KID becomes compulsory.
  • MiFID II: Further guidance on product governance requirements

    Amongst the numerous topics covered by the Markets in Financial Instruments Directive II (MiFID II), the European Securities and Markets Authority (ESMA) has decided to provide further guidance on the requirements regarding product governance through its guidelines dated 2 June 2017 which focus on the target market assessment by manufacturers and distributors of financial products.     
  • Arendt & Medernach is again the “Luxembourg Tax Firm of the Year”

    The partners of Arendt & Medernach are pleased to announce that their firm has been awarded once again the prestigious “Luxembourg Tax Firm of the Year” title during the International Tax Review’s European Tax Awards ceremony held at the Savoy Hotel in London on 18 May.
  • Signature of the Multilateral instrument – reservations made by Luxembourg

    On 7 June 2017, the official ceremony for the signing of the multilateral instrument (“MLI”) took place bringing to a close a process initiated last year when a consensus was reached on the wording of the MLI on 24 November 2016 (see also our newsflash dated 2 December 2016, available on our website www.arendt.com section Publications/Newsflash).
  • Arendt & Medernach: Luxembourg Law Firm of the Year

    Luxembourg, May 2017 – Arendt & Medernach is proud to have been named “Luxembourg Law firm of the year” both by Chambers & Partners and IFLR (International Financial Law Review). The prestigious trophies were both received in April in London at the respective ceremonies of the Chambers Europe Awards 2017 and the IFLR European Awards 2017.
  • First VAT EU case law on the cost-sharing VAT exemption

    The question of the scope of the cost-sharing VAT exemption, also referred to in the Council Directive 2006/112/EC of 28 November 2006 as amended ("EU VAT Directive") as “Independent Groups of Persons” or “IGPs”, is currently being debated at the Court of Justice of the EU (“CJEU”) in several cases. Last Thursday marked the first milestone regarding this specific VAT exemption since the CJEU released its judgment in the case Commission v Luxembourg (C-274/15).
  • An Introduction to Corporate Guarantee

    In the UAE, the risk management activities inherent in running a corporate or investment banking business remain of crucial importance, not least because of the strong local characteristic of “name lending”, by which is meant lending or providing other banking facilities to family or other private businesses, primarily on the strength of the “name” or “names” of the proprietors standing behind the business, rather than on the strength of the asset quality and underlying credit of the particular business. Of course, in practice, there is commercial overlap between the proprietors and the companies which they own, but the credit analyses can break down where poor banking practices and procedures result in poorly constructed legal documentation and gaps in guarantee and security support documents.